Reference #: 391874
Site Name: UK - Hertfordshire - Stevenage, Belgium-Wavre, UK - London - Brentford, USA - Massachusetts - Waltham, USA - North Carolina - Durham, USA - Pennsylvania - Upper Providence
Posted Date: Apr 30 2024A Director, Clinical Research and Early Programmes Immunology is sought to provide clinical and scientific insights to the immunology franchise including emerging indications and adjacencies. You will work within project teams to plan and assure delivery of clinical research and development activities. You will work withearly and late development teams to plan clinical development programs and facilitate close collaboration between different groupswithin the Respiratory&Inflammation Research Unit.The responsibilities of the Director Clinical Research and Early Programmes Immunologyinclude (but are not limited to) several key areas:designing and leading, as appropriate, clinicaldevelopment protocols/studies/programs in Immunology across all phases of development, as required by business imperatives as part of clinical and medicine development matrix teams.accountability for study Ph1-2/3 designproviding clinical expert input into regulatory documentation and leading regulatory interactions from clinical perspective for their studies/ indications, as appropriateworking closely with Research Unit members to define prioritised clinical indications for early targets and integrate inputs from across disciplines (scientific, clinical, commercial, regulatory and stats) to contribute to the Medicine Profile, Target Validation, Translational Plans, Candidate Selection., clinical development plan and integrated evidence planaccountability for design and delivery of an early clinical development plan that effectively demonstrates proof of mechanism, potential efficacy, and a safety profile to support progression to full developmentAnd/or accountability for design and delivery of the full development clinical development plan that effectively demonstrates benefit-risk and leads to a successful submission to regulators, payors etcaccountability for leading the integrated evidence planning to address the needs of regulators, payors and patientsparticipating/ leading the clinical Team (CT) (or equivalent cross-functional clinical team) and Integrated Evidence Team (IET)accountability for engaging external academic and clinical experts to enhance quality and delivery of clinicalprogrammes/ studiesaccountability, if medically qualified, for Medical Governance across the project to ensure scientific integrity and overall safety of the study subjects across all studies and other GSK activities/functions impacting safety and efficacy (i.e., manufacturing, formulation, etc.)accountability, if medically qualified, for providing medical monitoring and oversight of the safety of study participants on behalf of the Sponsor during the study and, together with the Safety Pharmacovigilance Physician, providing input into aspects of study design that relate to subject safetyaccountability for providing clinical input into presentations, supporting documentation for and participation in the governance bodies presentations, as requestedaccountability for escalation of clinical safety incidents to the Immunology Clinical Research and Early Programs Head and GSK Pharmacovigilance, as appropriateaccountability for clinical input to regulatory documentation to support the desired indication (e.g., IB, IMPD)responsibility for addressing clinical questions at meetings with regulatory authorities/ethics committeesaccountability for regulatory reporting requirements including Development Safety Update Reports (DSUR's) and IB updatesaccountability for incorporating patient perspective in the design and conduct of clinicalstudiesLeadershipYou will be experienced in drug development and/or translational medicine, preferably with industry experienceYou will e expected to work across multiple projects and be independently accountable for your own projectsYou will be expected to input into disease area strategy and be capable of executing this strategy based on your own expertise and that gained from your networkYou will play a leadership role in - medical governance initiatives in R&D (e.g., safety panel or governance board) - discovery/development policy, processes or guidelines, as requested by the business- or in professional networks in/outside of GSKYou will be able to input intorelevant business development activities representing, as requestedYou will be able to be mentoring and coaching other members of Clinical Research and Early Programmes Immunology - applying extensive knowledge of clinical development to more than one research unit/disease areaYou will be able to build an external network with academia/pharma, bringing expertise back to GSKYou will be able to anticipate, communicate, and suggest solutions on trends/events outside GSK that affect our business direction - utilizing command of the drug discovery and development process to influence a culture of continuous improvementCandidate ProfileBasic Qualifications:Doctor of Medicine OR'MD, PhD'ORPhD with industry experienceSignificant proven clinical or scientific expertisein rheumatology/dermatology/immunologyQualifications & Preferable ExpertiseIn addition to the above, the following will be highly desirable:Specialty training in rheumatology/dermatology/ immunology area, in particular lupus and adjacencies, would be advantageousIndustry experience in translational medicine and early/late phase drug development; experience of setting and executing scientific strategy, whilst being mindful of overall company goalsUnderstanding and knowledge of early/late drug development and translational sciencesExperience in working with relevant regulatory bodies and professionals in early/late stage discovery and developmentProject ManagementDemonstrates the discipline of risk-based planning, organizing, and managing resources to bring about the successful completion of specific project goals and objectivesin accordance with defined quality and time-based metrics.We're excited to be moving to our vibrant new home on New Oxford Street in central London from the end of June 2024. At GSK HQ, we're building an energising space where we can connect, collaborate and get ahead of disease together. Designed especially for us, it'll be one of the healthiest workplaces in the world, with best-in-class tech and bright, light spaces to help us thrive.Why GSK?
Uniting science, technology and talent to get ahead of disease together.GSK is a global biopharma company with a special purpose - to unite science, technology and talent to get ahead of disease together - so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns - as an organisation where people can thrive. We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/ immunology and oncology).Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it's also about making GSK a place where people can thrive. We want GSK to be a place where people feel inspired, encouraged and challenged to be the best the